Books, Book Chapters, Government Reports and Proceedings 1987-2006
1. Abeni, D., Perucci, C.A., Dolan, K., & Sangali, S. (1998). Prison and HIV-1 infection among injecting drug users. In: G. Stimson, D.C. Des Jarlias, & A. Ball (eds), Drug Injecting and HIV infection: Global Dimensions and Local Responses (pp 168-182). London: University College London Press.
2. Ali, R., Christie, P., Lenton, S., Hawks, D., Sutton, A., Hall, W., & Allsop, S. (1998). The Social Impacts of the Cannabis Expiation Notice Scheme in South Australia. Report to the Ministerial Council on Drug Strategy, 4 May 1998. Canberra: Department of Health and Family Services. (full report available)
3. Andrews, G., Hall, W., Teesson, M. & Henderson, S. (1999). The Mental Health of Australians. National Survey of Mental Health & Well-being Report No 2. Canberra: Mental Health Branch, Commonwealth Department of Aged Care.
4. Baker, A.L, & Dixon, J. (1991). Motivational interviewing for HIV risk-reduction. In: W.R Miller & S. Rollnick (eds), Motivational Interviewing: Preparing People to Change Addictive Behaviours. New York: Guilford.
5. Baker, A.L, Heather, N & Wodak, A. (1992). The application of self-control strategies to reducing HIV risk-taking behaviour in intravenous drug users. In: N. Heather, W.R Miller, & J Greeley (eds), Self-control and the Addictive Behaviours. Sydney: Maxwell MacMillan Publishing.
6. Barker, B., Burns, L., Copeland, J., Degenhardt, L., Demou, T., Dillon, P., McKetin, R., Ross, J., & Teesson, M. (2004). Double Trouble: Drugs and mental health. Sydney: National Drug and Alcohol Research Centre.
7. Barker, B., Conroy, E., Degenhardt, L., Kimber, J., & Dolan, K. (2003). Report to the NSW Cabinet Office of Drug Policy: Global Indicators for monitoring the illicit drug environment in NSW. Sydney: National Drug and Alcohol Research Centre.
8. Barker, B. and Degenhardt, L. (2003). Cross-national comparisons of drug-induced deaths. Sydney: National Drug and Alcohol Research Centre. (report available)
9. Barker, B., Degenhardt, L. and Breen, C. (2003). Indicators of drug use and treatment in Australia: Preliminary findings from the National Illicit Drug Indicators Project.Sydney: National Drug and Alcohol Research Centre. (report available)
10. Bell, J. & O’Connor, D. (1993). Methadone Prescribers Manual. AMPSAD, Sydney.
11. Bell, J. (1998). Delivering effective methadone treatment. In: J. Ward, R.P. Mattick & W.Hall (eds), Methadone Maintenance Treatment and Other Opioid Therapies (pp 161-176). Amsterdam: Harwood Academic Publishers.
12. Bell, J. (1998). Training health professionals to deliver methadone. In: J. Ward, R.P. Mattick & W.Hall (eds), Methadone Maintenance Treatment and Other Opioid Therapies (pp 361-378). Amsterdam: Harwood Academic Publishers.
13. Bell, J. & Hall, W. (1991). Does methadone maintenance reduce the criminal activity of opiate addicts? In: J. Hando (ed), Evaluation Clients and Treatments. NDARC Monograph No 11. Sydney: National Drug & Alcohol Research Centre.
14. Bell, J., Kimber, J., & Mattick R.P. (1999). Interim clinical guidelines: Use of naltrexone in relapse prevention for opioid dependence. Canberra: Commonwealth Department of Health and Aged Care.
15. Bell, J., Ward, J., Mattick, R.P., Hay, A., Chan, J., & Hall, W. (1995). An evaluation of private methadone clinics. NDS Research Report Series No. 4. Canberra: Australian Government Publishing Service.
16. Bell, J. & Wyndham, L. (1991). Screening for drug abuse – a community challenge. Clinical Biochemist Monograph No 5.
17. Berghuis, J., Swift, W., Roffman, R., Stephens, R., & Copeland, J. (2006). The Teen Cannabis Check-up: Exploring Strategies for Reaching Young Cannabis Users. In: R. Roffman & R. Stephens (eds.). Cannabis Dependence: Its Nature, Consequences and Treatment. pp 275-296. Cambridge University Press: Cambridge.
18. Black, E. & Degenhardt, L. (2005). Self-reported substance-related aggressive behaviour in the IDU sample, 2004. Drug Trends Bulletin June, Sydney: National Drug and Alcohol Research Centre.
19. Black, E., Dolan, K. & Wodak, A. (2004). Supply, demand and harm reduction strategies in Australian prisons: Implementation, cost and evaluation. ANCD Research Paper 9. Canberra: Australian National Council on Drugs. (full report available)
20. Buhrich, N., Hodder, T. & Teesson, M. (2003). Down and Out in Sydney (Vol 2). Caring for homeless people who have a mental health disorder. Sydney: Research Group in Mental Health and Homelessness.
21. Burns, L. & Teesson, M. (2001). Comorbidity between mental health and substance use disorders. In: G. Meadows & B. Singh (eds), Mental Health in Australia. Oxford University Press.
22. Channabasavanna, S., Paes, M. & Hall, W. (1999). Mental and behavioural disorders due to cannabis. In: H. Kalant, W. Corrigal, W. Hall & R. Smart (eds), The Health Effects of Cannabis. (pp ix-xi). Toronto: Addiction Research Foundation.
23. Chen, R., Mattick, R.P., & Baillie, A. (1993). Clients of Treatment Service Agencies: March 1992 Census Findings. Canberra: Australian Government Publishing Service.
24. Chesher, G., Fox, A., Greeley, J., Lemon, J., & Nabke, C. (1992). Investigation of the ‘Hangover” Effects of An Acute Dose of Alcohol on Psycomotor Performance. Final report of results from Consultancy 89/175, Federal Office of Road Safety.
25. Chesher, G. & Greeley, J. (1989). The effect of alcohol on cognitive and psychomotor functioning. In: J. Greeley & E. Gladstone (eds), The Effects of Alcohol on Cognitive Psychomotor and Affective Functioning. NDARC Monograph No 8. Sydney: National Drug & Alcohol Research Centre.
26. Chesher, G. & Greeley, J. (1989). The effects of alcohol on mood. In: J. Greenley & W. Gladstone (eds), The Effects of Alcohol on Cognitive, Psychomotor and Affective Functioning. NDARC Monograph No 8. Sydney: National Drug & Alcohol Research Centre.
27. Chesher, G., Greeley, J., & Saunders, J.B. (1989). Tolerance to the effects of alcohol. In: J. Greeley & W. Gladstone (eds), The effects of Alcohol on Cognitive, Psychomotor and Affective Functioning. NDARC Monograph No 8. Sydney: National Drug & Alcohol Research Centre.
28. Chesher, G. & Hall, W. (1999). The effects of cannabis on the cardiovascular and gastrointestinal systems. In: H. Kalant, W. Corrigal, W. Hall, & R. Smart (eds), The Health Effects of Cannabis. (pp ix-xi). Toronto: Addiction Research Foundation.
29. Conroy, A. & Copeland, J. (eds) (2000). Data Dictionary for Alcohol and Other Drug Treatment Services in New South Wales: Data guidebook for the NSW Minimum Data Set. Sydney: NSW Department of Health/National Drug and Alcohol Research Centre.
30. Conroy, A., Copeland, J., & Reid, A. (2000). AIHW National Survey of Alcohol and Other Drug Treatment Services: Report on NSW Findings. National Drug and Alcohol Research Centre Report to NSW Department of Health.
31. Cooke, M. (1996). Barriers to brief intervention. In: L. Topp & P. Dillon (eds), Looking to the future: A second generation of drug research. Proceedings from the Tenth National Drug and Alcohol Research Centre Annual Symposium (pp 104-118). Sydney: National Drug and Alcohol Research Centre.
32. Copeland, J. (1993). Issues for consideration in the treatment of women with alcohol and other drug problems. In: Women: Alcohol and Other Drugs – An Update on Health and Social Issues. Proceedings of an Eastern Area Health Service Workshop, 13-14.
33. Copeland, J. (1995). Women and Substance Abuse. In: Update in Women's Health: Strategies to Reduce Morbidity and Mortality (pp 183-190). Sydney: Alpha Biomedical Communications.
34. Copeland, J. (1999). Women and alcohol: Implications for road safety. In: Proceedings of the National Road Safety Summit 1998 (pp 121-127). Canberra: Federal Office of Road Safety.
35. Copeland, J. (2004). Cannabis. In: National Centre for Education and Training on Addiction (NCETA) Consortium (eds.). Alcohol and Other Drugs: A Handbook for Health Professionals. Canberra: Australian Government Department of Health and Ageing.
36. Copeland, J., Dillon, P., Mazurski, E., Yeung, N., Gascoigne, M., & Smith, A. (2005). Young Users’ Attitudes and Beliefs about Psychostimulants and School Drug Education. NSW Department of Education and Training: Sydney.
37. Copeland, J., Gerber, S., Dillon, P., & Swift, W. (2006). Cannabis: Answers To Your Questions. Australian National Council on Drugs: Canberra. (full report available)
38. Copeland, J., Gerber, S. & Swift, W. (2006). Evidence-based Answers to Cannabis Questions. Australian National Council on Drugs: Canberra. (full report available)
39. Copeland, J. & Howard, J. (1997). Substance abuse and juvenile crime. In: A. Borowski & I. O'Connor (eds), Juvenile Crime, Juvenile Justice and Juvenile Corrections (pp 167-189). Melbourne: Longman Cheshire.
40. Copeland, J., Howard, J. & Acuri, A. (2006) Young People in Detention. In: P. Aggleton, A. Ball & P. Mane (eds), Sex, Drugs and Young People – International Perspectives. Routledge: London.
41. Copeland, J. & Jarvis, T.J. (1997). Childhood sexual assault and the subsequent development of substance abuse among women. In: L.S. Harris (ed), Problems of Drug Dependence 1996: Proceedings of the 58th Annual Scientific Meeting, The College on Problems of Drug Dependence Inc. NIDA Research Monograph 174 (p 112). Rockville, MD: National Institute on Drug Abuse.
42. Copeland, J., Swift, W., Clement, N., & Reid, A. (2001). Young cannabis users’ attitudes and beliefs about cannabis and school drug education. Report prepared for the NSW Department of Education and Training. NSW Department of Education and Training, Student Services and Equity Programs.
43. Copeland, J., Swift, W., & Matalon, E. (2001). What’s the Deal on Quitting Cannabis? National Drug and Alcohol Research Centre: Sydney.
44. Copeland, J., Swift, W., & Matalon, E. (2001). Quitting Cannabis? Commonwealth Department of Health and Aged Care: Canberra.
45. Copeland, J. & Taylor, S. (2000). An overview of attitudes, knowledge and use patterns of alcohol, tobacco and other drugs in culturally and linguistically diverse communities in New South Wales: a DAMEC perspective. In: Proceedings of The Second Statewide Conference of the Drug and Alcohol Multicultural Education Centre - Community Partnerships (pp 3-10). Sydney.
46. Daly, K. & Maher, L. (1998). Criminology at the crossroads: Feminist readings of crime and justice. New York: Oxford University Press.
47. Darke, S. (1998). The effectiveness of methadone maintenance treatment 3: Moderators of treatment outcome. In: J. Ward, R.P. Mattick, & W. Hall (eds), Methadone Maintenance Treatment and Other Opioid Replacement Therapies (pp. 75-90). Amsterdam: Harwood Academic Publishers.
48. Darke, S., Cohen, J., Ross, J., Hando, J., & Hall, W. (1995). Transitions between routes of administration of regular amphetamine users. In: L.S. Harris (ed), Problems of Drug Dependence, 1994: Proceedings from the 56th Annual Scientific Meeting, The Problems of Drug Dependence, Inc. Vol II. NIDA Research Monograph 153.Rockville, MD: National Institute on Drug Abuse.
49. Darke, S., Degenhardt, L. & Mattick, R. (2007). Mortality amongst Illicit Drug Users. Cambridge: Cambridge University Press.
50. Darke, S. & Hall, W. (2000) Drug Trends Bulletin July 2000. Sydney: National Drug and Alcohol Research Centre.
51. Darke, S. & Kaye, S. (2000). Drug Trends Bulletin December 2000. Sydney: National Drug and Alcohol Research Centre.
52. Darke, S., Kelly, E. & Ross, J. (2003). Drug use and driving among injecting drug users. A monograph for police and policy makers. Payneham: Australasian Centre for Policing Research.
53. Darke, S., Ross, J., Hando, J., Hall, W., & Degenhardt, L. (2000). Illicit Drug Use in Australia: Epidemiology Use Patterns and Associated Harm. National Drug Strategy Monograph No 43. Canberra: Commonwealth Department of Health and Aged Care. (full report available)
54. Darke, S., Topp, L., & Kaye, S. (2001). Illicit Drug Reporting System Drug Trends Bulletin December 2001. Sydney: National Drug and Alcohol Research Centre.
55. Darke, S., Ward, J., Hall, W., Heather, N., & Wodak, A. (1991). Assessing opiate users: The Opiate Treatment Index (OTI). In: J. Hando (ed), Evaluating Clients and Treatments. NDARC Monograph No 11. Sydney: National Drug & Alcohol Research Centre.
56. Davidson, I., Rollnick, S., & MacEwan, I. (1991). Counselling the problem drinker. London: Routledge.
57. Dawe, S., Loxton, N., Hides, L., Kavanagh, D., & Mattick, R. (2002). Review of diagnostic screening instruments for alcohol and other drug use and other psychiatric disorders - 2nd edition. National Drug Strategy Monograph No 48. Canberra: Commonwealth Department of Health and Aged Care. (full report available)
58. Dawe, S. & Mattick, R.P. (1997). Review of diagnostic screening instruments for alcohol and other psychiatric disorders. Canberra: Australian Government Publishing Service. (full report available)
59. Day, C. (2003). Epidemiology of hepatitis C and HIV among Australian injecting drug users: a brief overview. In: Southgate, E., Day, C., Kimber, J., Weatherall, A., MacDonald, M., Woolcock, G., McGuckin, S., & Dolan, K. (eds). Dealing with risk: A multidisciplinary study of injecting drug use, hepatitis C and other blood-borne viruses in Australia. Australian National Council on Drugs, Canberra. pp 3-8. (full report available)
60. Day, C. & Dolan, K. (2001). Characteristics of Indigenous Injecting Drug Users in Sydney: gender, prison history and treatment experiences. Best Practice Interventions in Corrections for Indigenous People. Canberra: Australian Institute of Criminology.
61. Day, C., Dolan, K. & Post, J. (2003). Drugs and Bugs: a guide to injecting drug use and infections. Sydney: National Drug and Alcohol Research Centre.
62. Day, C., Woolcock, G. & Weatherall, A. (2003) National focus groups. In: Southgate, E., Day, C., Kimber, J., Weatherall, A., MacDonald, M., Woolcock, G., McGuckin, S., & Dolan, K. (eds). Dealing with risk: A multidisciplinary study of injecting drug use, hepatitis C and other blood-borne viruses in Australia. Australian National Council on Drugs, Canberra. pp 61-78. (full report available)
63. De Burgh, S.P.H. (1991). Alcohol and heart disease and the question of causality. In: Proceedings of the Conference on Medicinal Virtues of Alcohol in Moderation, Sydney, 30 October-1 November 1991. Victoria: The Medical Friends of Wine Society.
64. De Burgh, S. (1998). The distribution of alcohol consumption. In: M. Grant & J. Lifvak (eds), Drinking Patterns and their Consequences. Washington D.C., Taylor and Francis.
65. Degenhardt, L. (2001). Opioid Overdose Deaths in Australia. Sydney: National Drug and Alcohol Research Centre.
66. Degenhardt, L. and Barker, B. (2003). Cocaine and methamphetamine mentions in drug-induced deaths in Australia, 1997-2002. Sydney: National Drug and Alcohol Research Centre. (report available)
67. Degenhardt, L. and Barker, B. (2003). 2002 Australian Bureau of Statistics data on accidental opioid induced deaths. Sydney: National Drug and Alcohol Research Centre. (report available)
68. Degenhardt, L., & Day, C. (eds) (2004). The course and consequences of the heroin shortage in New South Wales. NDLERF Monograph Series No. 3. National Drug Law Enforcement Research Fund: Adelaide. (executive summary available)
69. Degenhardt, L. & Day, C. (2006). Impact of the heroin shortage: Additional research. NDLERF Monograph Series No. 19. National Drug Law Enforcement Research Fund: Adelaide.
70. Degenhardt, L., Day, C. & Hall, W. (eds) (2004). The causes, course and consequences of the heroin shortage in Australia. NDLERF Monograph Series No. 3. National Drug Law Enforcement Research Fund: Adelaide. (executive summary available)
71. Degenhardt, L., Day, C., Hall, W., & Bewley-Taylor, D.R. (2007). The Australian 'heroin shortage' six years on: What, if any, are the implications for drug policy? Briefing Paper 12. The Beckley Foundation Drug Policy Program.
72. Degenhardt, L., Hall, W., & Lynskey, M. (2004). What is comorbidity and why does it occur? In: Teesson, M. & Proudfoot, H. (eds). Comorbid mental disorders and substance use disorders: epidemiology, prevention and treatment. Canberra: Australian Government Department of Health and Ageing. (full report available)
73. Degenhardt, L., Hall, W., Warner-Smith, M., & Lynskey, M. (2004). Illicit drug use. In: M. Ezzati, A.D. Lopez, A. Rodgers, & C.J.L. Murray (eds), Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors Volume 1 , (pp 1109-1175). Geneva: Switzerland.
74. Degenhardt, L. & Roxburgh, A. (2007). 2005 Cocaine and methamphetamine related drug-induced deaths in Australia. Sydney: National Drug and Alcohol Research Centre. (report available)
75. Degenhardt, L. & Roxburgh, A. (2007). Accidental drug-induced deaths due to opioids in Australia, 2005. Sydney: National Drug and Alcohol Research Centre. (report available)
76. Degenhardt, L., Roxburgh, A. and Black, E. (2004). Cocaine and amphetamine mentions in accidental drug-induced deaths in Australia, 1997-2003. Sydney: National Drug and Alcohol Research Centre. (report available)
77. Degenhardt, L., Roxburgh, A. and Black, E. (2004). 2003 Australian Bureau of Statistics data on accidental opioid induced deaths. Sydney: National Drug and Alcohol Research Centre. (report available)
78. Degenhardt, L., Roxburgh, A. Black, E. & Dunn, M. (2006). Accidental drug-induced deaths due opioids in Australia, 2004. Sydney: National Drug and Alcohol Research Centre. (report available)
79. Degenhardt, L., Roxburgh, A. Black, E. & Dunn, M. (2006). 2004 Cocaine and amphetamine related drug-induced deaths in Australia. Sydney: National Drug and Alcohol Research Centre. (report available)
80. Dickerson, M., Wodak, A., Mattick, R., & Hill, S. (2001). Problem Drinking/Problem Gambling: A Study of Co-morbid Individuals in NSW. Sydney: University of Western Sydney.
81. Dietze, P., Miller, P., Clemens, S., Matthews, S., Gilmour, S., & Collins, L. (2004). The course and consequences of the heroin shortage in Victoria. NDLERF Monograph Series No. 6. National Drug Law Enforcement Research Fund: Adelaide. (executive summary available)
82. Dietze, P., Richards, J., Rumbold, G., Aitken, C., Day, C., McGregor, C., & Ritter, A. (2002). Treatment utilisation by heroin dependent persons in Australia: Implications for treatment service systems. Melbourne: Turning Point Alcohol and Drug Centre Inc.
83. Dillon, P. (2002). Foreword to T. McGill, Facing Drugs a guide for parents. Sydney: Griffin Press.
84. Dillon, P. (2003). Inhalants. Sydney: National Drug and Alcohol Research Centre.
85. Dillon, P. (2003). New risks from recreational substances. In: Club Health. The 2nd International Conference on Night-Life, Substance Use and Related Health Issues. 24th-27th March 2002, Fiera District, Rimini, Italy: Proceedings. 24-32.
86. Dillon, P., Cox, G. & O’Connor, M. (2004). What’s the score? The facts on alcohol, drugs and sport. Canberra: Australian Sports Commission Publications.
87. Dillon, P. & Dolan, K. (2000). Needle and syringe programs: your questions answered. Sydney: National Drug and Alcohol Research Centre.
88. Dillon, P., Peters, R., Copeland, J., & Beel, A. (1998). The quest for the body beautiful: Male anabolic-androgenic steroid use in NSW. In: Conference Proceedings: 2nd National Men's Health Conference 1997 (pp 100-105). Perth: Men's Health Teaching and Research Unit, School of Public Health, Curtin University of Technology.
89. Dillon, P. & Vogl, L. (2006). Young Men and Alcohol. Sydney: National Drug and Alcohol Research Centre.
90. Dillon, P. & Vogl, L. (2006). Young Women and Alcohol. Sydney: National Drug and Alcohol Research Centre.
91. Dixon, D. & Maher, L. (1999) Walls of silence. In: G. Hage & R. Couch (eds), The future of Australian multiculturalism. Sydney: Research Institute for Humanities and Social Sciences.
92. Dolan, K. (1996). HIV prevalence and transmission in prisons. In: L. Topp & P. Dillon (eds), Looking to the future: A second generation of drug research. Proceedings from the Tenth National Drug and Alcohol Research Centre Annual Symposium (pp 126-139). Sydney: National Drug and Alcohol Research Centre.
93. Dolan, K. (1997). AIDS drugs and risk behaviour in prison: State of the art. In: J. Nelles & A. Fuhrer (eds), Harm Reduction in Prison (pp 213-238). Bern: Swiss Federal Office of Public Health.
94. Dolan, K. (1997). Why is there conflicting evidence of HIV transmission in prison? In: O. O'Brien (ed), Report of the 3rd European Conference on Drug and HIV/AIDS Services in Prison (pp 19-21). London: Cranstoun Drug Services, London.
95. Dolan, K., Day, C., Southgate, E., & Jenkins, C. (2002). Effectiveness of interventions for marginalized and particularly vulnerable IDUs including prisoners, indigenous, MSM, and sex workers. 2001 Global Research Network Meeting on HIV Prevention in Drug-Using Populations. Fourth Annual Meeting Report. October 11-12, 2001 Melbourne, Australia (p 33-35). National Institutes of Health, US Department of Health and Human Services.
96. Dolan, K. & Crofts, N. (1999). A review of risk behaviours, transmission and prevention of blood borne viral infections in Australian prisons. In: D. Shewan & J.B. Davies (eds), Drug Use and Prisons. An International Perspective. (pp 215-232). London: Harwood Academic Publishers.
97. Dolan, K., Hall, W., & Wodak, A. (1998). The provision of methadone within prison settings. In: J. Ward, R.P. Mattick, & W. Hall (eds), Methadone Maintenance Treatment and Other Opioid Replacement Therapies (pp 379-396). Amsterdam: Harwood Academic Publishers.
98. Dolan, K., Khoei, E.M., Brentari, C., & Stevens, A. (2007). Prisons and Drugs: A global review of incarceration, drug use and drug services. Report 12 Oxford: Beckley Foundation.
99. Dolan, K., Topp, L., & MacDonald, M. (2000). Needle and syringe programs: a review of the evidence. National Drug and Alcohol Research Centre, Sydney.
100. Donnelly, N. & Hall, W. (1994). Patterns of cannabis use in Australia. National Drug Strategy Monograph Series No 27. Canberra: Australian Government Publication Service.
101. Donnelly, N., Hall, W., & Christie, P. (1999). Effects of the Cannabis Expiation Notice Scheme on levels and patterns of cannabis use in South Australia: Evidence from the National Drug Strategy Household Surveys 1985-1995. National Drug Strategy Research Monograph No 37. Canberra: Australian Government Publishing Service. (full report available)
102. Donoghoe, M., Hall, W., Ball, A., & Lopez, A. (1998). Opioid Overdose: Trends, risk factors, interventions and priorities for action. Geneva: Substance Abuse Department, World Health Organization.
103. Dray, A., Mazerolle, L., Perez, P. & Ritter, A. (2008) Drug Law Enforcement in an Agent-Based Model: Simulating the Disruption to Street-Level Drug Markets. In Dr Lin Liu and Dr John Eck (Eds) Artificial Crime Analysis Systems: Using Computer Simulations and Geographic Information Systems (pp. 352-371). Hershey, PA: Idea Group Publishing.
104. Dwyer, R., Fry, C., Carruthers, S., Bolleter, A., Dolan, K., Donald, A., Byrne, J., & Loxley, W. (2002). The Australian Blood-borne virus Risk and Injecting Drug Use Study (ABRIDUS): A national study of hepatitis C risk practices and contexts in Melbourne, Perth and Sydney. Fitzroy: Turning Point Alcohol & Drug Centre Inc.
105. Elkins, L. & Richmond, R. (1989). Women and Smoking: The Choice is Yours. Sydney: NSW Department of Health.
106. Elkins, L. & Richmond, R. (1991). Outcome results of the Smokescreen programme after being conducted in a hospital clinic and onsite in the workplace. In: The Global War: Proceedings of the Seventh World Conference on Smoking and Health, Perth, April 1990, (pp 639-644).
107. Fox, G.A. & Fox, A.M. (1991). A neuropsychological test for diffuse brain damage. In: W.R. Levick, B.G. Frost, M. Watson, & H.P. Pfister (eds) Brain Impairment: Advances in Applied Research, Proceedings of the 15th Annual Conference of the Australian Society for the Study of Brain Impairment (pp 165-171), University of Newcastle,.
108. Fox, A.M., Nabke, C., Chesher, G., Greeley, J., & Lemon, J. (1993). Acute and hangover effects of alcohol on event-related potentials (ERPs). In: H.D. Utzelmann, G. Berghaus, & G. Kroj (eds), Alcohol, Drugs and Traffic Safety – T92, Proceedings of the 12th International Conference on Alcohol, Drugs and Traffic Safety, Cologne, (pp 649-652).
109. Fry, A. & Teesson, M. (1999) Blacktown Youth Suicide Prevention Project: Hospital and Health Services Protocols 1.2.1 Final Report. Sydney: University of Western Sydney.
110. Gladstone, W. & Greeley, J. (1987). Methadone treatment: Principles policy and practice. In: J. Greeley & W. Gladstone (eds), Methadone Programs in Australia: Policy and Practice. NDARC Monograph No 1. Sydney: National Drug & Alcohol Research Centre.
111. Gowing, L., Proudfoot, H., Henry-Edwards, S., & Teesson, M. (2001). Evidence supporting treatment: the effectiveness of interventions for illicit drug use. ANCD Research Paper 3. Canberra: Australian National Council on Drugs.
112. Gray, D., Shaw, G., d’Abbs, P., Brooks, D., Stearns, A., Mosey, A., & Spooner, C. (2006). Policing, volatile substance misuse, and Indigenous Australians. NDLERF Monograph Series No. 16. National Drug Law Enforcement Research Fund: Adelaide. (full report available)
113. Greeley, J. & McDonald, D. (eds) (1990). Alcohol and Human Behaviour (Research Paper No 14) Canberra: Royal Commission into Aboriginal Deaths in Custody.
114. Greeley, J. D., Pead, J., Murray, T., Pahoki, S., Ritter, A., Felstead, B., Mattick, R.P., & Heather, N. (1995). Preliminary outcome of cue exposure treatment for alcohol dependence. In: L. S. Harris (ed), Problems of Drug Dependence 1994: Proceedings of the 56th Annual Scientific Meeting - The College on Problems of Drug Dependence Volume II: Abstracts (p 233). National Institute on Drug Abuse Research Monograph 153. Rockville, MD: National Institutes of Health.
115. Greeley, J., Swift, W., & Heather, N. (1993). Desire to drink or not to drink in alcohol-dependent patients in treatment. In: L.S. Harris (ed), Problems of drug dependence 1991: Proceedings of the 53rd Annual Scientific Meeting of the Committee on Problems of Drug Dependence, Inc NIDA Research Monograph No. 132 (p 212). Rockville, MD: National Institute on Drug Abuse.
116. Greeley, J., Swift, W., Prescott, J., & Heather, N. (1993). Cue reactivity in heavy and light drinkers. In: L.S. Harris (ed), Problems of drug dependence 1991: Proceedings of the 53rd Annual Scientific Meeting of the Committee on Problems of Drug Dependence, Inc. NIDA Research Monograph No. 119 (p 325). Rockville, MD: National Institute on Drug Abuse.
117. Greeley, J. & Westbrook, F. (1991). Associative learning, drug use and addictive behaviour. In: N. Heather, W.R. Miller & J. Greeley (eds), Self-control and the Addictive Behaviors. Sydney: Maxwell MacMillan.
118. Hall, W. (1990). A survey of early and brief intervention research in Australia. In: J. Carless & W. Hall (eds), Proceedings from the National Workshop into Early/Brief Interventions for Drug and Alcohol Problems. NDARC Monograph No 9. Sydney: National Drug and Alcohol Research Centre.
119. Hall, W. (1994). Cannabis use and mental health. Proceedings of the 1994 APSAD National Conference: Alcohol, Drugs and the Family. Sydney, APSAD.
120. Hall, W. (1995). Substance abuse. In: A. Jorm (ed), Men and Mental Health. Canberra: National Health and Medical Research Council, Australian Government Publishing Service.
121. Hall, W. (1996). What have populations surveys revealed about substance use disorders and their comorbidity with other mental disorders? In: Substance Use and Mental Illness: Proceedings of the Fourth Lingard Symposium. Newcastle: Hunter Institute of Mental Health.
122. Hall, W. (1998). Cannabis use and psychosis. In: M.Teehan & D. Chong (eds), Having it Both Ways: Problematic Drug and Alcohol Use and Mental Illness. Melbourne: Jesuit Social Services.
123. Hall, W. (1999). Assessing the health and psychological effects of cannabis use. In: H. Kalant, W. Corrigal, W. Hall, & R. Smart (eds), The Health Effects of Cannabis. (pp ix-xi). Toronto: Addiction Research Foundation.
124. Hall, W. (1999) Heroin and other opioid overdose deaths in Australia. In: Heroin Crisis. (pp 170-176). Melbourne: Bookman Press.
125. Hall, W. (2000). The mental health effects of cannabis use. (pp 550-553). In: M. Gelder, J.J. Lopez-Ibor & N. Andreasen (eds), New Oxford Textbook of Psychiatry. Oxford University Press.
126. Hall, W. (Chair) (2000) Report of the Working Party on the Use of Cannabis for Medical Purposes. Volume 1: Executive Summary. Sydney: NSW Government. (full report available)
127. Hall, W. (Chair) (2000) Report of the Working Party on the Use of Cannabis for Medical Purposes. Volume 2: Full Report. Sydney: NSW Government. (full report available)
128. Hall, W. (2002). Gewohnheitsmaiger cannabiskonsum und Telinahme am Straenverkehr. In: F. Grotenhermen and M. Karus (eds), Cannabis, Straenverkehr und Arbeitswelt. Berlin: Springer.
129. Hall, W. & Bird, K.D. (1991). Statistical inference in psychiatric research. In: V.J. Carr, H. Eshkevari, R. Kalucy, & R. Kosky (eds), Mental Health and Illness: A Textbook for Australasian Health Science Students. Sydney: Butterworth-Heinemann.
130. Hall, W., Degenhardt, L., & Lynskey, M. (2002). The health and psychological effects of cannabis use. Monograph Series No 44, Canberra: Commonwealth of Australia. (full report available)
131. Hall, W., Doran, C., Degenhardt, L., & Shepard, D. (2006). Illicit opiate abuse. In: Jamison, D., Breman, J., Measham, A., Allenye, G., Claeson, M., Evans, D., Jha, P., Mills, A, & Musgrove (eds), Disease Control Priorities in Developing Countries. World Bank and Oxford University Press: New York.
132. Hall, W., & Hando, J. (1993). Patterns of illicit psychostimulant use in Australia. In: D. Burrows, B. Faherty, & M. MacAvoy (eds), Illicit Psychostimulant Use in Australia. Canberra: National Campaign Against Drug Abuse.
133. Hall, W. & Hunter, E.M. Australia. In: D. Heath (ed), International Handbook on Alcohol and Culture. Greenwood Press.
134. Hall, W., Johnston, L. & Donnelly, N. (1999) The epidemiology of cannabis use and its consequences. In: H. Kalant, W. Corrigal, W. Hall, & R. Smart (eds), The Health Effects of Cannabis. (pp ix-xi). Toronoto: Addiction Research Foundation.
135. Hall, W., Lynskey, M., & Teesson, M. (2001) What is comorbidity and why does it matter? In: M. Teesson & L. Burns (eds), National Comorbidity Project. Canberra: Commonwealth Department of Health and Aged Care.
136. Hall, W. & Nelson, J. (1995). Public perceptions of the health and psychological consequences of cannabis use. National Drug Strategy Monograph No 29. Canberra: Australian Government Publishing Service.
137. Hall, W., Room, R. & Bondy, S. (1999) Comparing the health and psychological risks of alcohol, cannabis, nicotine and opiate use. In: H. Kalant, W. Corrigal, W. Hall & R. Smart (eds), The Health Effects of Cannabis (pp ix-xi). Toronto: Addiction Research Foundation.
138. Hall, W., Solowij, N. & Lemon, J. (1994). The health and psychological effects of cannabis use. National Drug Strategy Monograph Series No 25. Canberra: Australian Government Publication Service. (full report available)
139. Hall, W. & Swift, W. (2006). Policy implications of cannabis dependence. In: R.A. Roffman, & R.S. Stephens (eds.), Cannabis dependence: Its nature, consequences and treatment (International Research Monographs in the Addictions). London: Cambridge University Press.
140. Hall, W. & Teesson, M. (1999) Alcohol use disorders: Who should be treated and how? In: G. Andrews & A.S. Henderson (eds), Unmet need in psychiatry: Problems, resources, responses. (pp 290-301). Cambridge University Press.
141. Hall, W. & Teesson, M. (2000) Alcohol-use disorders: who should be treated and how? In: Andrews, G. & Henderson, S. (eds), Unmet Need in Psychiatry. Problems, Resources, Responses. (pp 290-301). Cambridge: Cambridge University Press.
142. Hall, W., Ward, J., & Hando, J. (1992). The effectiveness of methadone maintenance treatment: Implications for a proposed trial of injectable heroin maintenance. In: G. Brammer & G. Gerrard (eds), Heroin Treatment – New Alternatives. Canberra: National Centre for Epidemiology and Population Health.
143. Hall, W., Ward, J., & Mattick, R.P. (1997). The role of drug maintenance treatment in the management of drug dependence. In: D. Sellman, G. Robinson, R. McCormick, & G. Dore (eds), The Long and the Short of Treatment for Alcohol and Drug Disorders, Christchurch: Department of Psychological Medicine, Christchurch School of Medicine.
144. Hall, W., Ward, J. & Mattick, R. (1998). The effectiveness of methadone maintenance treatment 1: Heroin use and crime. In: J. Ward, R.P. Mattick & W. Hall (eds), Methadone Maintenance Treatment and Other Opioid Replacement Therapies (pp 17-58). Amsterdam: Harwood Academic Publishers.
145. Hall, W., Ward, J., & Mattick, R. (1998). The future of opioid replacement therapy. In: J. Ward, R.P. Mattick & W. Hall (eds), Methadone Maintenance Treatment and Other Opioid Replacement Therapies (pp 443-462). Amsterdam: Harwood Academic Publishers.
146. Hall, W., Ward, J. & Mattick, R.P. (1998). The role of drug maintenance in the treatment of drug dependence. pp 77-91. In: D. Sellman, G.Robinson, R. McCormick, & G. Dore (eds), The Long and the Short of Treatment for Alcohol and Drug Disorders. Christchurch: Department of Psychological Medicine, Christchurch School of Medicine.
147. Hallett, J., Indig, D., Aloi, A., Byrne, G., Copeland, J., Crocker, C., Doyle, S., Hanley, E., Holmes, J., Lawrinson, P., Leary, J., Manzie, R., Nesire, V., Pierce, L., Tynan, M. & Young, M. (2002). NSW Minimum Dataset for Alcohol and Other Drug Treatment Service: Data Dictionary and Collection Guidelines 2002-2003. Version 2 July. Sydney: New South Wales Department of Health and the National Drug and Alcohol Research Centre, University of New South Wales.
148. Hando, J. (1996). Treatment needs of regular amphetamine users in Sydney. In: Topp, L. & Dillon, P. (eds), Looking to the future: A second generation of drug research. Proceedings from the Tenth National Drug and Alcohol Research Centre Annual Symposium (pp 1-30). Sydney: National Drug and Alcohol Research Centre.
149. Hando, J., & Hall, W. (1993). Amphetamine Use Among Young Adults in Sydney, Australia. Research Grant Report Series No. B93/2 Sydney, NSW Drug & Alcohol Directorate.
150. Hando, J. & Hall, W. (1996). Patterns of amphetamine misuse in Australia. In: H. Klee (ed), Amphetamine misuse - International Perspectives on Current Trends. Chur, Switzerland: Harwood Academic Publishers.
151. Hando, J. & Hall, W. (1997). Drug availability and crime among amphetamine uses in Australia: Implications for law enforcement. In: Australian Bureau of Criminal Intelligence. Australian Illicit Drug Report 1996-1997. Canberra: Australian Bureau of Criminal Intelligence.
152. Hando, J. & Hall, W. (1997). Patterns of amphetamine misuse in Australia. In: H. Klee (ed), Amphetamine Misuse: International Perspectives on Current Trends. Reading: Harwood Academic Publishers.
153. Hando, J., Hall, W., Rutter, S. & Dolan, K. (1999). Current state of research on illicit drugs in Australia: An information document. Canberra: National Health and Medical Research Council, Commonwealth of Australia.
154. Hando, J., Topp, L., & Dillon, P. (1998). Associated harms and risk-taking behaviour. In: P. Dillon, L. Topp, & W. Swift (eds), Illicit Drugs: Current Issues and Responses. Proceedings from the Eleventh National Drug and Alcohol Research Centre Annual Symposium, November 1997. Monograph No 37. Sydney: National Drug and Alcohol Research Centre.
155. Harris, K., Richmond, R., & Holt, P. (1993). Smoking cessation rates: the hospital clinic versus the worksite program. Proceedings of the 8th World Conference on Tobacco or Health. Buenos Aires.
156. Heather, N. (1987). DRAMS for problem drinkers: The potential of a brief intervention by general practitioners and some evidence of its effectiveness. In: T. Stockwell & S. Clement (eds), Helping the Problem Drinker: New Initiatives in Community Care. London: Croom Helm.
157. Heather, N. (1988). Research priorities at the National Drug and Alcohol Research Centre. In: J. Greeley & N. Heather (eds), Towards a National Drug and Alcohol Research Network. NDARC Monograph No 3. Sydney: National Drug & Alcohol Research Centre.
158. Heather, N. (1989). A fresh look at ‘loss of control’. In: J. Greeley & N. Heather (eds), Perspectives on Drug and Alcohol Dependence. NDARC Monograph No 6. Sydney: National Drug & Alcohol Research Centre.
159. Heather, N. (1989). Evaluation of intervention and outcome: How do we know if it works? In Proceedings of the International Congress on Alcohol, Other Drugs and the Family. Sydney: Alcohol and Drug Foundation.
160. Heather, N. (1989). Brief intervention strategies. In: R.K. Hester & W.R. Miller (eds), Handbook of Alcoholism Treatment Approaches. New York: Pergamon Press.
161. Heather, N. (1989). Controlled drinking treatment: Where do we stand today? In: T. Loberg, W.R. Miller, P.E. Nathan, & G.A. Marlatt (eds), Addictive Behaviours: Prevention and Early Intervention. Amsterdam: Swets and Zeitlinger.
162. Heather, N. (1989). A fresh look at loss of control. In: P.F. Lovibond & P. Wilson (eds), Proceedings of the XXIV International Congress of Psychology, Vol 9: Clinical and Abnormal Psychology. Amsterdam: Elsevier Science Publishers B V.
163. Heather, N. (1990). Treatment of alcohol problems: With special reference to the behavioural approach. In: D.K. Balfour (ed), Psychotropic Drugs of Abuse. London: Pergamon Press.
164. Heather, N. (1990). Antabuse treatment for alcohol problems: Is it effective and, if so, why? In: C. Brewer (ed), Effective Treatment Options in Addiction. London: Gaskell Monongraph, The Royal College of Psychiatrists.
165. Heather, N. (1991). Foreword to I. Davidson, S. Rollnick, & I. MacEwan (eds), Counselling the Problem Drinker: London: Routledge.
166. Heather, N. (1991). Impaired control over alcohol consumption. In: N. Heather, W.R. Miller & J. Greeley (eds), Self-control and the Addictive Behaviours. Sydney: Maxwell MacMillan Publishing.
167. Heather, N. (1993). “Antabuse treatment for alcohol problems: is it effective and , if so, why?” In: C. Brewer (ed), Medical Management of Alcohol and Opiate Abuse. London: Gaskell Monographs, The Royal College of Psychiatrists.
168. Heather, N. (1993). Application of harm-reduction principles to the treatment of alcohol problems. In: N. Heather, A. Wodak, E. Nadelmann, & P. O’Hare (eds),Psychoactive Drugs and Harm Reduction: From Faith to Science. London: Whurr Publications.
169. Heather, N. (1993). “No Quick Fix” and the Australian drug and alcohol research agenda: a reply to Pederson, Montague and Webster. In: M. Balzer (ed), Drug and Alcohol Research and Evaluation: Concepts and Priorities. A Report on AMPSAD’s National Conference 1992. Sydney: Australia Medical and Professional Society on Alcohol and Other Drugs.
170. Heather, N. (1993). The role of research in the National Drug Strategy. In: M. Balzer (ed), Drug and Alcohol Research and Evaluation: Concepts and Priorities. A Report on AMPSAD’s National Conference 1992. Sydney: Australian Medical and Professional Society on Alcohol and Other Drugs.
171. Heather, N., Batey, R., Saunders, J.B., & Wodak, A. (1989). The effectiveness of treatment for drug and alcohol problems. An overview. National Drug Strategy Monograph Series No 11. Canberra: Australian Government Publication Service. (full report available)
172. Heather, N. & Greeley, J. (1989). Cue exposure: An alternative model for the prevention of relapse in the addictive disorders. In: B.F.S Grenyer & N. Solowij (eds), Cognitive-behavioural Approaches to the Treatment of Drug and Alcohol Problems. NDARC Monograph No 7. Sydney: National Drug and Alcohol Research Centre.
173. Heather, N., Miller, W.R., & Greeley, J.D. (eds) (1991). Self-control and the Addictive Behaviours. Sydney: Pergamon Press.
174. Heather, N., Richmond, R,, Webster, I., & Wodak, A. (1989). A Guide to Healthier Drinking. Sydney: Clarendon Printing.
175. Heather, N. & Robertson, I. (1989). Problem Drinking (Revised Edition). Oxford: Oxford University Press.
176. Heather, N. & Stallard, A. (1989). Does the Marlatt model underestimate the importance of conditioned craving in the relapse process? In: M. Gossop (ed), Relapse and Addictive Behaviour. London: Croom Helm.
177. Heather, N. & Tebbutt, J. (eds) (1989). The Effectiveness of Treatment for Drug and Alcohol Problems: An Overview. NCADA Monograph Series, No 11. Canberra: Australian Government Publishing Service.
178. Heather, N., Wodak, A., Nadelmann, E., & O’Hare, P. (eds) (1993). Psychoactive Drugs and Harm Reduction: From Faith to Science. London: Whurr Publications.
179. Heather, N., Wodak, A., Nadelmann, E., & O’Hare, P. (1993). Preface to N. Heather, A. Wodak, E. Nadelmann, & P. O’Hare (eds) Psychoactive Drugs and Harm Reduction: From Faith to Science. London: Whurr Publications.
180. Henry-Edwards, S., Ali, R., Bisshop, P., Gordon, S., & Hall, W. (2000). Options for Control of Performance and Image Enhancing Drugs. Prepared on Behalf of the National Expert Advisory Committee on Illicit Drugs. Ministerial Council on Drug Strategy, July 2000.
181. Howe, D., Temple, L., Mackson, C. & Teesson, M. (1999). ’Catch Us If U Can!’ Young People and Psychiatric Illness – Intervention & Assessment (YPPI-IA) Final Report. Sydney: YPPI Centre.
182. Humeniuk, R., Ali, R., White, J., Hall, W., & Farrell, M. (2000). Proceedings of Expert Workshop on the Induction and Stabilisation of Patients onto Methadone. National Drug Strategy Monograph Series No. 39. Canberra: Australian Government Publication Service. (full report available)
183. Hunter, E.M., Brady, M., & Hall, W. (2000). National Recommendations for the Clinical Management of Alcohol-related Problems of Indigenous Primary Health Care Settings. Canberra: Commonwealth Department of Health and Aged Care.
184. Hunter, E.M., Brady, M., & Hall, W. (2000). An analysis of needs for services for alcohol-related problems in Indigenous communities in Far North Queensland. Department of Social and Preventive Medicine, University of Queensland.
185. Hunter, E.M., Brady, M., Hall, W., Arlidge, L., & Eltringham, A. (1998). Services relating to Alcohol in Indigenous Communities: A Report to the office of Aboriginal and Torres Strait Islander Health Services. Department of Social and Preventive Medicine, University of Queensland.
186. Jarvis, T. & Duquemin, A. (1991). Research into drug and alcohol issues for women: Where are the gaps? How can these best be addressed? In: Changing the Research Story: Women and Drugs. Proceedings of the Women and Drugs Research Workshop, February (pp 438-440). Melbourne.
187. Jarvis, T., Tebbutt, J., & Mattick, R.P. (1995). Treatment approaches for alcohol and drug dependence. John Wiley and Sons. Sussex, England.
188. Jones, C., Donnelly, N., Swift, W., & Weatherburn, D. (2005). Driving under the influence of cannabis: the problem and potential countermeasures. Crime and Justice Bulletin 87, Sydney: NSW Bureau of Crime Statistics and Research.
189. Kalant, H., Corrigal, W., Hall, W. & Smart, R. (eds) (1999). The Health Effects of Cannabis. Toronto: Addiction Research Foundation.
190. Kalant, H., Corrigal, W., Hall, W. & Smart, R. (1999). Introduction. In: H. Kalant, W. Corrigal, W. Hall & R. Smart (eds), The Health Effects of Cannabis. (pp ix-xi). Toronto: Addiction Research Foundation.
191. Kimber, J. & Day, C. (2003). Quality of Life. In: E. Southgate, C. Day, J. Kimber, A. Weatherall, M. MacDonald, G. Woolcock, S. McGuckin, & K. Dolan (eds). Dealing with risk: A multidisciplinary study of injecting drug use, hepatitis C and other blood-borne viruses in Australia. Australian National Council on Drugs, Canberra. pp 79-84. (full report available)
192. Kimber, J. & van Beek, I. (2003). Consumption rooms: the Australian experience. Akzeptanz 10, 54-58.
193. Kinner, S., Fowler, G., Fischer, J., Stafford, J., & Degenhardt, L. (2005). Monitoring the ecstasy market in Australia – challenges and successes. Party Drug Trends Bulletin April, Sydney: National Drug and Alcohol Research Centre.
194. Larance, B., Dillon, P, & Degenhardt, L. (2005). Performance and image enhancing drugs. Sydney: National Drug and Alcohol Research Centre.
195. Lawrinson, P. & Copeland, J. (2002). Measuring treatment outcomes for clients of alcohol and other drug treatment services. In: J. Sansoni & L. Tilley (eds) , Health Outcomes 2002: Current Challenges and Future Frontiers. Proceedings of the 8th Annual National Health Outcomes Conference. Canberra: Australian Health Outcomes Collaboration.
196. Lawrinson, P. & Copeland, J. (2002). Measuring Treatment Outcomes for Clients of Alcohol and Other Drug Treatment Services. In: J.D. Sellman (ed), New Zealand Treatment Research Monograph, Alcohol, Drugs and Addiction. Research Proceedings from the Cutting Edge Conference, September 2002. Wellington.
197. Lemon, J., Greeley, J., Fox, A., Chesher, G., & Nabke, C. (1993). The effects of ‘hangover’ on psychomotor performance twelve hours after drinking. In: H.D. Utzelmann, G. Berghaus & G. Kroj (eds), Alcohol, Drugs and Traffic Safety – T92 Proceedings of the 12th International Conference on Alcohol, Drugs and Traffic Safety (pp 653-656). Cologne.
198. Lintzeris, N., Clark, N., Ritter, A., Ali, R., Bell, J., Gowing, L., Hawken, L., Henry-Edwards, S., Mattick, R.P., Monheit, B., Newton, I., Quigley, A., Whicker, S., White, J. (2001). National clinical guidelines and procedures for the use of buprenorphine in the treatment of heroin dependence. Canberra: Commonwealth Department of Health and Aged Care.
199. Loxley, W., Carruthers, S., Wodak, A., Crofts, N., Dolan, K., Gaughwin, M. & Kaldor, J. (1995). Patterns of infection. National AIDS Bulletin 9(2), 26-27.
200. Lynskey, M. (1998). A longitudinal study of cannabis use during adolescence. In: P. Dillon, L. Topp, & W. Swift (eds), Illicit Drugs: Current Issues and Responses. Proceedings from the Eleventh National Drug and Alcohol Research Centre Annual Symposium, November 1997. Monograph No 37. Sydney: National Drug and Alcohol Research Centre.
201. Lynskey, M. (2001). Alcohol use and violent behaviour among youth: results from a longitudinal study. In: P. Williams (ed), Alcohol, Young Persons and Violence. Australian Institute of Criminology Research and Public Policy Series No. 35, Canberra.
202. Lynskey, M. & Hall, W. (2000). Educational outcomes and adolescent cannabis use. Sydney: NSW Department of Education and Training.
203. Lynskey, M. & Sussman, S. (2001). Pilot Studies. In: S. Sussman (ed), Handbook of Program Development for Health Behavior Research and Practice. California: Sage Publications.
204. MacDonald, M., Robotin, M., & Topp, L. (2001). Drug use trends among injecting drug users (IDU): Findings from the Australian Needle and Syringe Program (NSP) Survey, 1995-2000. Drug Trends Bulletin, October 2001. Sydney: National Drug and Alcohol Research Centre.
205. MacDonald, M. & Topp, L. (2000). Drug Trends Bulletin October 2000. Sydney: National Drug and Alcohol Research Centre.
206. McGregor, C., Ali, R., Darke, S., & Christie, P. (1997). Benzodiazepine use among heroin users in Adelaide, Australia: patterns and preferences. In: K. Dyer & D. Addy (eds), New Perspectives: Proceedings of the 1997 NCETA Research Seminar Program. Adelaide: National Centre for Education and Training on Addiction.
207. McGregor, C., Hall, K., Ali, R., Christie, P., Braithwaite, R., & Darke, S. (1999). It's rarely just the 'h': addressing overdose among South Australian heroin users through a process of intersectoral collaboration. Drug and Alcohol Services Council of South Australia Monograph No 2. Parkside: Drug and Alcohol Services Council.
208. McKetin, R. & Darke, S. (2000). Drug Trends Bulletin April 2000. Sydney: National Drug and Alcohol Research Centre.
209. McKetin, R., Dillon, P., Finney-Lamb, Stewart, S., & Ho, G. (2007). Fast Facts on Ice. Sydney: National Drug and Alcohol Research Centre.
210. McKetin, R., Mattick, R., Ward, P., Catts, S., & Bell, J. (1996). Amphetamine use: Changes in mood, memory and attention. In: L. Topp & P. Dillon (eds), Looking to the future: A second generation of drug research. Proceedings from the Tenth National Drug and Alcohol Research Centre Annual Symposium (pp 31-45). Sydney: National Drug and Alcohol Research Centre.
211. McKetin, R. & McLaren, J. (2004). The methamphetamine situation in Australia: A review of routine data sources. NDLERF Monograph Series No. 1. National Drug Law Enforcement Research Fund: Adelaide. (executive summary available)
212. McKetin, R., McLaren, J. & Kelly, E. (2005). The Sydney methamphetamine market: Patterns of supply, use, personal harms and social consequences. NDLERF Monograph Series No. 13. National Drug Law Enforcement Research Fund: Adelaide. (executive summary available)
213. McLaren, J. & Mattick, R.P. (2007). Cannabis in Australia: Use, supply, harms, and responses. National Drug Strategy Monograph No.57. Canberra: Australian Government Department of Health and Ageing.
214. Maher, L. (1997). Sexed work: Gender, race and resistance in a Brooklyn drug market. Oxford: Oxford University Press.
215. Maher, L., Dixon, D., Swift, W., & Nguyen, T. (1997). Annh hai: Young Asian background people’s perceptions and experiences of policing. Research Monograph Series: UNSW Faculty of Law.
216. Maher, L., Nguyen, T. & Le, T. (1999). Wall of silence: Stories of Cabramatta street youth. In: R. White (ed), Australian youth subcultures. Hobart: National Clearinghouse for Youth Studies.
217. Mant, A. (1991). Women and substance abuse. In: D. Saltman (ed), Women and Health: An Introduction to Issues. Sydney: Harcourt Brace Jovanovich.
218. Mant, A. (1992). Intervention. In: L. Price (ed), Staff Development Manual. Committee for International Day Against Drug Abuse and Illicit Trafficking, June 26 1991, Sydney.
219. Mant, A. (1992). Prescribing and the Use of Psychotropic Drugs: Ideal, ideology and rationally In: TRANX National Conference on Benzodiazepine (Minor Tranquilliser) Use, October 25, 1991, La Trobe University Union.
220. Mant, A., Hall, W., Hu,W., & Whicker, S.D. (1992). A Drug and Alcohol Educational Network for Doctors. Report to the NCADA, April 1992.
221. Mattick, R.P. (1990). Social phobia: An overview of psychological concepts and treatments. In: N. McNaughton and G. Andrews (eds), Anxiety. Dunedin, New Zealand: Otago University Press.
222. Mattick, R.P. (1991). Approaches to the Evaluation of Treatment Services for Problems of Drug Abuse. Commissioned Report to the World Health Organisation Project on Assessing Standards of Care in Drug Abuse Treatment. Geneva: WHO.
223. Mattick, R.P. (1992). Psychoactive substance dependence and associated states. In: S. Schwartz (ed), Case Studies in Abnormal Psychology. Brisbane: John Wiley and Sons.
224. Mattick, R.P. (1996). Substance dependence and abuse. Chapter 9, In: P.R. Martin & J.S. Birnbrauer (eds), Clinical Psychology Profession and Practice in Australia, (pp. 236-260). Melbourne: MacMillan.
225. Mattick, R.P., & Andrews, G. (1994). Social phobia. In: M. Hersen & R. T. Ammerman (eds), Handbook of prescriptive treatments for adults (pp.157-178). New York: Plenum Press.
226. Mattick, R.P. & Baillie, A.J. (eds) (1992). An outline for approaches to smoking cessation: Quality Assurance Project. NCADA Monograph Series No 19. Canberra: Australian Government Publishing Service.
227. Mattick, R.P.M., Baillie, A., Grenyer, B., Hall, W., Hando, J., Jarvis, T., Ward, J. & Webster, P. (1993). A treatment outline for approaches to opioid dependence: quality assurance project. National Drug Strategy Monograph Series No 21. Canberra: Australian Government Publishing Service.
228. Mattick, R.P.M., Baillie, A., Grenyer, B., Hall, W., Jarvis, T., & Webster, P. (1993). An outline for the management of alcohol problems: quality assurance project. National Drug Strategy Monograph Series, No 20. Canberra: Australian Government Publishing Service.
229. Mattick, R.P., Bell, J., & Hall, W. (1994). Psychiatric morbidity, antisocial personality disorder, and treatment response in methadone maintenance patients. In: L. S. Harris (ed), Problems of Drug Dependence 1993: Proceedings of the 55th Annual Scientific Meeting - The College on Problems of Drug Dependence Volume II: Abstracts National Institute on Drug Abuse Research Monograph 141 (p.332). Rockville, MD: National Institutes of Health.
230. Mattick, R.P., Digiusto, E., Doran, C., O'Brien, S., Shanahan, M., Kimber, J., Henderson, N., Breen, C., Shearer, J., Gates, J., Shakeshaft, A., & NEPOD Trial Investigators (2001). National Evaluation of Pharmacotherapies for opioid Dependence (NEPOD): Report of results and recommendations. National Drug Strategy Monograph Series No 52. Canberra: Australian Department of Health and Ageing. (full report available)
231. Mattick, R.P. & Franks, F.B. (1991). Development and implementation of Australian standards of care for drug and alcohol treatment services. In: J. Orley (ed), National Perspectives on Quality Assurance in Mental Health Care (pp 71-78). Geneva: WHO.
232. Mattick, R.P., & Hall, W. (1993). A treatment outline for approaches to opioid dependence: Quality assurance in the treatment of drug dependence project. National Campaign Against Drug Abuse Monograph No 21. Canberra: Australian Government Publishing Service.
233. Mattick, R.P., & Jarvis, T. (1993). An outline for the management of alcohol problems: Quality assurance in the treatment of drug dependence project. National Campaign Against Drug Abuse Monograph No 20. Canberra: Australian Government Publishing Service.
234. Mattick, R.P., Oliphant, D.A., Bell, J., & Hall, W. (1996). Psychiatric morbidity in methadone maintenance patients: prevalence, effect on drug use and detection. In: Substance Use and Mental Illness: Proceedings of the Fourth Liongard Symposium. Newcastle: Hunter Institute of Mental Health.
235. Mattick, R.P., Oliphant, D., Ward, J., & Hall, W. (1998). The effectiveness of other opioid replacement therapies: LAAM, heroin, buprenorphine, naltrexone and injectable maintenance. In: J. Ward, R.P. Mattick & W. Hall (eds), Methadone Maintenance Treatment and Other Opioid Replacement Therapies (pp 123-157). Amsterdam: Harwood Academic Publishers.
236. Mattick, R.P., Page, A., & Lampe, L. (1995). Cognitive and behavioural aspects of social phobia. In: M. B. Stein (ed), Social phobia: Clinical and research perspectives (pp 189-228). Washington, D.C.: American Psychiatric Press.
237. Mattick, R.P., Peters, L., & Clarke, J. C. (1991). Exposure and cognitive restructuring for social phobia: A controlled study. In K.M. McConkey & N.W. Bond (eds), Readings in Australian Psychology. Sydney: Harcourt, Brace, Jovanovich.
238. Mattick, R.P., Ward, J., & Hall, W. (1998). The role of counselling and psychological therapy. In: J. Ward, R.P. Mattick & W. Hall (eds), Methadone Maintenance Treatment and Other Opioid Replacement Therapies (pp 265-304). Amsterdam: Harwood Academic Publishers.
239. Maxwell, J., Davey, J., & Dillon, P. (1998). Comparison of patterns of illicit drug use in Australia and the United States. Austin, Texas: Texas Commission on Alcohol and Drug Abuse.
240. Miller, V., Robertson, S., Kellehear, K., Teesson, M., Farhall, J., Issakidis, C., Peters, J., Swensdon, C., Bland, R., & Epstein, M. (eds) (2000) Whose Dreams? Whose Realities? Proceedings of the 9th Annual THEMHS Conference, Melbourne, Australia, Rozelle: Standard Publishing House.
241. Miller, W.R. & Rollnick, S. (1991). Motivational Interviewing: Preparing People to Change Addictive Behaviours. New York: Guildford.
242. Mitchell, P., Spooner, C., Copeland, J., Vimpani, G., Toumbourou, J., Howard, J., & Sanson, A. (2001). The role of families in the development, identification, prevention and treatment of illicit drug problems. Commissioned by the National Health and Medical Research Council for the Strategic Research Development Committee’s National Illicit Drug Strategy Research Program. Canberra: Commonwealth of Australia.
243. Nabke, C. (1993). The chronic and acute effects of alcohol on memorising strategies, free-recall and event-related potentials in heavy and light male social drinkers. Co-supervision with J. Cranney, UNSW. Research thesis, Master of Psychology (Clinical), UNSW. Submitted March, 1993.
244. O’Brien, S. (2004). Treatment options for heroin and other dependence: A guide for frontline workers. Canberra: Australian Government Department of Health and Ageing.
245. O’Brien, S. (2004). Treatment options for heroin and other dependence: A guide for families and carers. Canberra: Australian Government Department of Health and Ageing.
246. O’Brien, S. (2004). Treatment options for heroin and other dependence: A guide for users. Canberra: Australian Government Department of Health and Ageing.
247. O'Brien, S. & Swift, W. (2005). Mental health and adolescent cannabis use. Sydney: NSW Department of Education and Training.
248. Oldenberg, B. & Lemon, J. (1992). Drug Use Among a Cohort of Sydney Teenagers in 1985, 1986 & 1988. A Report from the University of Sydney, Department of Public Health.
249. Pead, J., Greeley, J.D., Ritter, A., Murray, T., Felstead, B., Mattick, R., & Heather, N. (1994). A clinical trial of cue exposure combined with cognitive-behavioural treatment for alcohol dependence. In: L.S. Harris (ed), Problems of Drug Dependence 1993: Proceedings of the 55th Annual Scientific Meeting - The College on Problems of Drug Dependence Volume II: Abstracts. National Institute on Drug Abuse Research Monograph 141 (p.332). Rockville, MD: National Institutes of Health.
250. Penrose-Wall, J., Copeland, J., & Harris, M. (2000) Shared care of illicit drug problems by general practitioners and primary health care providers: A literature review, A report for the National Illicit Drug Strategy. Sydney: Centre for Integration Studies and National Drug and Alcohol Research Centre, UNSW.
251. Penrose-Wall, J., Harris, M., & Copeland, J. (2000) Program Guide: Sharing Mental Health Care Vol 2 Alcohol and Other Drug Problems. A Guide for Divisions of General Practice. Sydney: Integration Studies and National Drug and Alcohol Research Centre, UNSW.
252. Peters, R., Copeland, J., & Dillon, P. (1998). Patterns and correlates of anabolic-androgenic steroid use. In: P. Dillon, L. Topp, & W. Swift (eds), Illicit Drugs: Current Issues and Responses. Proceedings from the Eleventh National Drug and Alcohol Research Centre Annual Symposium, November 1997. Monograph No 37. Sydney: National Drug and Alcohol Research Centre.
253. Peters, R., Copeland, J., Dillon, P., & Larance, B. (2006). Muscle Boundaries, HIT, Liverpool.
254. Prescott, J. (1987). Research issues in methadone maintenance. In J. Greeley & W. Gladstone (eds) Methadone Programs in Australia: Policy and Practice. NDARC Monograph No 1. Sydney: National Drug & Alcohol Research Centre.
255. Proudfoot, H. & Teesson, M. (2004). Conclusion: Comorbid mental disorders and substance use disorders: epidemiology, prevention and treatment. In: Teesson, M. & Proudfoot, H. (eds). Comorbid mental disorders and substance use disorders: epidemiology, prevention and treatment. Canberra: Australian Government Department of Health and Ageing. (full report available)
256. Proudfoot, H., Teesson, M., Brewin, E., & Gournay, K. (2004). Comorbidity and delivery of services. In: Teesson, M. & Proudfoot, H. (eds). Comorbid mental disorders and substance use disorders: epidemiology, prevention and treatment. Canberra: Australian Government Department of Health and Ageing. (full report available)
257. Proudfoot, H., Teesson, M. & Dillon, P. (2005). Feeling good? Answering your questions about alcohol, drugs and mental health. Canberra: Australian Government Department of Health and Ageing. (pdf of resource available)
258. Rees, V., Copeland, J., & Swift, W. (1998). Brief cognitive behavioural interventions for cannabis dependence. In: P. Dillon, L. Topp & W. Swift (eds), Illicit Drugs: Current Issues and Responses. Proceedings from the Eleventh National Drug and Alcohol Research Centre Annual Symposium, November 1997. Monograph No 37. Sydney: National Drug and Alcohol Research Centre.
259. Rees, V., Copeland, J., Swift, W., Roffman, R. & Stephens, R. (1999) Brief cognitive behavioural interventions for cannabis dependence. In: L.S. Harris (ed), Problems of Drug Dependence 1998: Proceedings of the 60th Annual Scientific Meeting, The College on Problems of Drug Dependence Inc. NIDA Research Monograph 179, (p.79). Rockville, MD: National Institutes of Health.
260. Richmond, R.L. (1991). Smokescreen: A decade of experience conducting research in general practice for smokers. In: J. Hando (ed), Evaluating Clients and Treatment. NDARC Monograph No 11. Sydney: National Drug & Alcohol Research Centre.
261. Richmond, R.L., Elkins, L., Mendelsohn, C., & Rollnick, S. (1991). Smokers: You Have a Right to Know. Sydney: NSW Department of Health.
262. Richmond, R.L., Elkins, L., Mendelsohn, C., & Rollnick, S. (1991). Smokers: The Choice is Yours. Sydney: NSW Department of Health.
263. Richmond, R.L., Elkins, L., Mendelsohn, C., & Rollnick, S. (1991). Taking Action to Stop Smoking. Sydney: NSW Department of Health.
264. Richmond, R.L., Elkins, L., Mendelsohn, C., & Rollnick, S. (1991). Self-help for Smokers. Sydney: NSW Department of Health.
265. Richmond, R.L., Heather, N., Holt, P., & Hu, W. (1991). A survey of policies and programmes for tobacco, alcohol and drugs in the top 600 companies in Australia. In: Proceedings of the Conference on Alcohol and Drugs in the Workplace – Reducing the Costs, Melbourne, April 18-19, 1991. Canberra: Department of Health, Housing and Community Services.
266. Richmond, R.L., Makinson, R., Giugni, A., & Webster, I. (1991). General practitioner smoking interventions in Australia: Results of studies over the past ten years. In: The Global War: Proceedings of the Seventh World Conference on Tobacco and Health, Perth, April 1990 (pp 657-660).
267. Richmond, R.L. & Wakefield, D. (eds) (1989). Sexually Transmitted Diseases and the AIDS Epidemic. New York: Harcourt Brace Jovanovich.
268. Richmond, R. L., Webster, I., Elkins, L., Mendelsohn, C., & Rollnick, S. (1991). Smokescreen for the 1990’s: A Stop Smoking Programme for General Practitioners to Use with Smokers. Sydney: NSW Department of Health.
269. Richmond, R.L., Webster, I., & Heather, N. (1990). Drug Use Amongst Youth: Patterns, Psychological Factors and Prevention. Document prepared for the Parliamentary Standing Committee on Social Issues.
270. Ritter, A. (2008). Heroin: Injected with uncertainty. In Bammer, G and Smithson, M (Eds) Uncertainty: Multidisciplinary perspectives on risk (pp. 157-169). London: Earthscan.
271. Robertson, S., Kellehear, K., Teesson, M. & Miller, V. (eds) (1999). Making History: Shaping the Future. Contemporary THEMHS in Mental Health Services. Rozelle: Standard Publishing House.
272. Rollnick, S. & Bell, A. (1991). Brief motivational interviewing for the non-specialist. In: W.R. Miller & S. Rollnick, Motivational Interviewing: Preparing People to Change Addictive Behaviours. New York: Guildford.
273. Rollnick, S. & MacEwan, I. (1991). Alcohol counselling in context. In: R. Davidson, S. Rollnick, & I. MacEwan (eds), Counselling the Problem Drinker. London: Routledge.
274. Ross, J. & Darke, S. (1998). Benzodiazepine dependence and psychopathology among heroin users. In: P. Dillon, L. Topp, & W. Swift (eds), Illicit Drugs: Current Issues and Responses. Proceedings from the Eleventh National Drug and Alcohol Research Centre Annual Symposium, November 1997. Monograph No 37. Sydney: National Drug and Alcohol Research Centre.
275. Ross, J., Darke, S., & Hall, W. (1996). Benzodiazepine injecting among heroin users. In: L. Topp & P. Dillon (eds), Looking to the future: A second generation of drug research. Proceedings from the Tenth National Drug and Alcohol Research Centre Annual Symposium (pp 140-150). Sydney: National Drug and Alcohol Research Centre.
276. Ross, M.W., Wodak, A., Miller, M.E., & Gold, J. (1992). Attitudes towards termination of pregnancy and associated risk behaviours in drug-injecting women. In: F. Melica (ed), AIDS and Reproduction: Proceedings of the First International Conference, Genoa (pp 55-60). Basel, Karger.
277. Roxburgh, A. (2003). Family Drug Support: Analysis of calls made to the Family Drug Support telephone service April 2000 to November 2002.
278. Roxburgh, A. & Degenhardt, L. (2006). Drug-related hospital stays in Australia, 1993-2005. Sydney: National Drug and Alcohol Research Centre. (report available)
279. Shand, F., Gates, J., Fawcett, J., & Mattick, R. (2003). The Treatment of Alcohol Problems: A Review of the Evidence. Canberra: Commonwealth Department of Health and Ageing.
280. Shand, F. & Mattick, R.P. (2002). Clients of treatment service agencies: May 2001 census findings. National Drug Strategy Monograph No. 47. Canberra: Australian Government Publishing Service. (full report available)
281. Shearer, J. & Gowing, L. (2004). Pharmacological Interventions In: Baker, A., Lee, N.K. & Jenner, L. (eds) , Models of intervention and care for psychostimulant users, Second Edition. National Drug Strategy Monograph Series No. 51. Canberra: Australian Government Department of Health and Ageing.
282. Shearer, J., Johnston, J., Kaye, S., Dillon, P., & Collins, L. (2005). Characteristics and dynamics of cocaine supply and demand in Sydney and Melbourne. NDLERF Monograph Series No. 14. National Drug Law Enforcement Research Fund: Adelaide. (full report available)
283. Shewan, D., Stover, H. & Dolan, K. (2005). Injecting in prisons. In: Pates, R., McBride, A. & Arnold, K. (eds), Injecting illicit drugs, (pp 69-81). London: Blackwell Publishing.
284. Smith, R., Hunter, E., Spargo, R., & Hall, W. (1990). A Summary of Research Findings on Health and Lifestyle Presented to Kimberley Aboriginal Communitites. Canberra: CSIRO Division of Human Nutrition.
285. Solowij, N. (1998). Cannabis and Cognitive Functioning. Cambridge, UK: Cambridge University Press.
286. Solowij, N. (1999). Long-term effects of cannabis on the central nervous system. I Brain function and neurotoxicity. II Cognitive functioning. In: H. Kalant, W. Corrigal, W. Hall & R. Smart (eds), The Health Effects of Cannabis. (pp 195-265). Toronto: Addiction Research Foundation.
287. Solowij, N. & Grenyer, B.F.S. (2002). Long-term effects of cannabis on psyche and cognition. In: F. Grotenhermen & E. Russo (eds), Cannabis and Cannabinoids: Pharmacology, Toxicology and Therapeutic Potential. pp. 299-312, New York, Haworth Press.
288. Solowij, N. & Lee, N. (1991). A survey of Ecstasy (MDMA) Users in Sydney. Research Grant Report Series No. B91/1 Sydney, NSW Drug & Alcohol Directorate.
289. Southgate, E., Day, C. & Dolan, K. (2003). Introduction In: E. Southgate, C. Day, J. Kimber, A. Weatherall, M. MacDonald, G. Woolcock, S. McGuckin, & K. Dolan (eds). Dealing with risk: A multidisciplinary study of injecting drug use, hepatitis C and other blood-borne viruses in Australia. Australian National Council on Drugs, Canberra. pp1-2. (full report available)
290. Southgate, E., Day, C., Dolan, K., Kimber, J., McGuckin, S., Woolcock, G., MacDonald, M., & Weatherall, A. (2003). Dealing with risk: a synthesis of findings from this report. In: E. Southgate, C. Day, J. Kimber, A. Weatherall, M. MacDonald, G. Woolcock, S. McGuckin, & K. Dolan (eds). Dealing with risk: A multidisciplinary study of injecting drug use, hepatitis C and other blood-borne viruses in Australia. Australian National Council on Drugs, Canberra. pp 85-89. (full report available)
291. Southgate, E., Day, C., Kimber, J., Weatherall, A., MacDonald, M., Woolcock, G., McGuckin, S., & Dolan, K. (2003). Dealing with risk: A multidisciplinary study of injecting drug use, hepatitis C and other blood-borne viruses in Australia. Australian National Council on Drugs, Canberra. (full report available)
292. Southgate, E. & Weatherall, A. (2003). Sydney case study: Kings Cross. In: E. Southgate, C. Day, J. Kimber, A. Weatherall, M. MacDonald, G. Woolcock, S. McGuckin, & K. Dolan (eds). Dealing with risk: A multidisciplinary study of injecting drug use, hepatitis C and other blood-borne viruses in Australia. Australian National Council on Drugs, Canberra. pp 20-50. (full report available)
293. Spooner, C. (1996). Bridging the gap between research and practice: A case study. In: L. Topp & P. Dillon (eds), Looking to the future: A second generation of drug research. Proceedings from the Tenth National Drug and Alcohol Research Centre Annual Symposium (pp 1-30). Sydney: National Drug and Alcohol Research Centre.
294. Spooner, C. (1998). Primary prevention of psychoactive substance-related harm: A review. Report prepared for the World Health Organization, Sydney.
295. Spooner, C., Hall, W., & Lynskey, M. (2001). Structural determinants of youth drug use. ANCD Research Paper 2. Canberra: Australian National Council on Drugs. (full report available)
296. Spooner, C., Mattick, R., & Hall, W. (1999). Suspended sentences with treatment orders: A proposed framework for diversion pilot projects. Report prepared for NSW Intersectoral Taskforce on Recidivism of Drug & Alcohol Offenders. CJ Spooner: Planning Research & Evaluation & NDARC, Sydney, 1999.
297. Spooner, C., McPherson, M. & Hall, W. (2004). The role of police in preventing and minimising illicit drug use and its harm. NDLERF Monograph Series No. 3. National Drug Law Enforcement Research Fund: Adelaide. (full report available)
298. Stafford, J., Degenhardt, L. & Agaliotis, M. (2005). Examining injecting, sexual and driving risk behaviours among regular ecstasy users in Australia by gender and age. Party Drug Trends Bulletin June, Sydney: National Drug and Alcohol Research Centre.
299. Stallard, A. & Heather, N. (1989). Relapse prevention and AIDS among intravenous drug users. In: M. Gossop (ed), Relapse and Addictive Behaviour. London: Groom Helm.
300. Stephens, R., Roffman, R., Copeland, J., & Swift, W. (2006). Cognitive Behavioural and Motivational Enhancement Treatments. In: R. Roffman & R. Stephens (eds.). Cannabis Dependence: Its Nature, Consequences and Treatment. pp 131-153. Cambridge University Press: Cambridge.
301. Stewart, J. (1991). Evaluation of a specialist drug and alcohol service for women. In: J. Hando (ed), Evaluating Clients and Treatment. NDARC Monograph No 11. Sydney: National Drug & Alcohol Research Centre.
302. Stewart, J. (1991). Gender-sensitive treatment services? An evaluation Pro-Ed (No 3), 5-9.
303. Stewart, J. (1991). Evaluation of a specialist drug and alcohol treatment service for women. In: Proceedings of the 1991 National Women and Drugs Conference, Melbourne, February 10-12, 1991 (pp 214-226). Melbourne: Addiction Research Institute of Victoria.
304. Stewart, J. (1991). The Jarrah House evaluation research experience. Changing the Research Story: Women and Drugs, Proceedings of the Women and Drugs Research Workshop, February 10-12, 1991(pp 45-46).Melbourne: Addiction Research Institute of Victoria.
305. Swift, W., Clement, N., Copeland, J., Martin, G., Roffman, R.A., Berghuis, J., Stephens, R.S., & Howard, J. (2001). What’s The Deal On Grass? Talking with a young person about cannabis. Sydney: National Drug and Alcohol Research Centre.
306. Swift, W., Clement, N., Copeland, J., Martin, G., Roffman, R.A., Berghuis, J., Stephens, R.S., & Howard, J. (2001). What’s The Deal On Grass? Cannabis facts for young people. Sydney: National Drug and Alcohol Research Centre.
307. Swift, W., Clement, N., Copeland, J., Martin, G., Roffman, R.A., Berghuis, J., Stephens, R.S., & Howard, J. (2001). What’s The Deal On Grass? Cannabis facts for parents. Sydney: National Drug and Alcohol Research Centre.
308. Swift, W., Copeland, J., & Hall, W. (1996). Characteristics and Treatment Needs of Women with Alcohol and Other Drug Problems: Results from an Australian Survey. National Drug Strategy Research Report Series, No 7. Canberra: Australian Government Publishing Service.
309. Swift, W. & Hall, W. (2001). Dependence. In: F. Grotenhermen (ed), Cannabis and Cannabinoids: Pharmacology and Therapeutic Potential. pp. 283-294, Verlag Hans Huber, Bern (German Edition).
310. Swift, W. & Hall, W. (2002). Tolerance, withdrawal and dependence. In: F. Grotenhermen & E. Russo (eds), Cannabis and Cannabinoids: Pharmacology, Toxicology and Therapeutic Potential. pp. 257-268, New York, Haworth Press.
311. Swift, W., Hall, W., & Copeland, J. (1996). Patterns and consequences of long term cannabis use. In: L. Topp & P. Dillon (eds), Looking to the future: A second generation of drug research. Proceedings from the Tenth National Drug and Alcohol Research Centre Annual Symposium (pp 46-79). Sydney: National Drug and Alcohol Research Centre.
312. Swift, W., Hall, W., & Copeland, J. (1998). One year on: A follow-up of long-term cannabis smokers. In: P. Dillon, L. Topp, & W. Swift (eds), Illicit Drugs: Current Issues and Responses. Proceedings from the Eleventh National Drug and Alcohol Research Centre Annual Symposium, November 1997. Monograph No 37. Sydney: National Drug and Alcohol Research Centre.
313. Swift, W., Hall, W., & Copeland, J. (1999). Cannabis dependence: a one year follow-up of long-term cannabis users. In: L.S. Harris (ed), Problems of Drug Dependence 1998: Proceedings of the 60th Annual Scientific Meeting, The College on Problems of Drug Dependence Inc. NIDA Research Monograph 179, (p 79). Rockville, MD: National Institutes of Health.
314. Teesson, M. (2001) Background: causes, prevention and treatment of comorbidity. In: Teesson, M. & Burns, L. (eds), National Comorbidity Project. Canberra: Commonwealth Department of Health and Aged Care.
315. Teesson, M. & Burns, L. (eds) (2001) National Comorbidity Project. Canberra: Commonwealth Department of Health and Aged Care.
316. Teesson, M., Degenhardt, L., & Hall, W. (2002). Addictions. London: Psychology Press, Taylor & Francis Group.
317. Teesson, M., Degenhardt, L., Hall, W., Lynskey, M., Toumbourou, & Patton, G. (2005). Substance use and mental health in longitudinal perspective. In: T. Stockwell, P.J. Gruenewald, J.W. Toumbourou & W. Loxley (eds), Preventing Harmful Substance Use: The Evidence for Policy and Practice, (pp 43-51). Chichester: England.
318. Teesson, M. & Hall, W. (2001). Substance-related disorders. In: G. Meadows & B. Singh (eds), Mental Health in Australia: A Collaborative Community Practice (pp 363-373). Oxford University Press.
319. Teesson, M., Hall, W., Lynskey, M., & Degenhardt, L. (2000). The epidemiology of drug dependence in Australia: findings from the National Survey of Mental Health and Wellbeing. In: L.S. Harris (ed), Problems of Drug Dependence, 1999: Proceedings of the 61st Annual Scientific Meeting, The College on Problems of Drug Dependence, Inc. NIDA Research Monograph 180. Rockville, MD: National Institutes of Health.
320. Teesson, M., Hodder, T., & Buhrich, N. (1998). Drug dependence among the homeless in Sydney, Australia. In: L.S. Harris (ed), Problems of Drug Dependence, 1997: Proceedings of the 59th Annual Scientific Meeting, The College on Problems of Drug Dependence, Inc. NIDA Research Monograph 179. Rockville, MD: National Institutes of Health.
321. Teesson, M. & Proudfoot, H. (2002). Interventions for alcohol dependence, abuse and excessive drinking. National Alcohol Research Agenda.Canberra: Commonwealth Department of Health and Ageing.
322. Teesson, M. & Proudfoot, H. (eds) (2004). Comorbid mental disorders and substance use disorders: epidemiology, prevention and treatment. Canberra: Australian Government Department of Health and Ageing. (full report available)
323. Teesson, M. & Proudfoot, H. (2004). Responding to comorbid mental disorders and substance use disorders. In: Teesson, M. & Proudfoot, H. (eds). Comorbid mental disorders and substance use disorders: epidemiology, prevention and treatment. Canberra: Australian Government Department of Health and Ageing. (full report available)
324. Topp, L. (1996). Cue reactivity in amphetamine users. In: L. Topp & P. Dillon (eds), Looking to the future: A second generation of drug research. Proceedings from the Tenth National Drug and Alcohol Research Centre Annual Symposium (pp 46-79). Sydney: National Drug and Alcohol Research Centre.
325. Topp, L., Hando, J., & Dillon, P. (1998). Ecstasy I: Patterns and context of use. In: P. Dillon, L. Topp, & W. Swift (eds), Illicit Drugs: Current Issues and Responses. Proceedings from the Eleventh National Drug and Alcohol Research Centre Annual Symposium, November 1997. Monograph No 37. Sydney: National Drug and Alcohol Research Centre.
326. Topp, L., McKetin, R., Hando, J., & Hando, J. (2001). A Users’ Guide To Speed. Sydney: National Drug and Alcohol Research Centre.
327. Trauer, T., Rosen, A., Cummins, R., & Teesson, M. (2000). What’s new in outcome measurement. In: V. Miller et al (eds), Whose Dreams? Whose Realities? Proceedings of the 9th Annual THEMHS Conference, Melbourne, Australia (pp 235-243). Rozelle: Standard Publishing House.
328. Vogl, L. & Teesson, M. (2006). The efficacy of a computerised school based prevention program for problems with alcohol use: Climate Schools. Alcoholism Clinical & Experimental Research (Supplement June) 30: 29th Annual Meeting of the Research Society on Alcoholism, June 23-29 – Baltimore, Maryland, 198A.
329. Ward, J., Mattick, R., & Hall, W. (1991). Assessment of Opioid Dependence and Suitability for Methadone Maintenance. Report prepared for the Drug & Alcohol Directorate, NSW Department of Health.
330. Ward, J., Mattick, R., & Hall, W. (1991). Duration of Methadone Maintenance. Report prepared for the Drug & Alcohol Directorate, NSW Department of Health.
331. Ward, J., Mattick, R., & Hall, W. (1991). Methadone Maintenance and Pregnancy. Report prepared for the Drug & Alcohol Directorate, NSW Department of Health.
332. Ward, J., Mattick, R., & Hall, W. (1992). Counselling Psychotherapy and Psychopathology. Report prepared for the Drug & Alcohol Directorate, NSW Department of Health.
333. Ward, J., Mattick, R., & Hall, W. (1992). Methadone Maintenance and Pregnancy. Report prepared for the Drug & Alcohol Directorate, NSW Department of Health.
334. Ward, J., Mattick, R., & Hall, W. (1992). Withdrawal Regimens at the End of Methadone Maintenance. Report prepared for the Drugs & Alcohol Directorate, NSW Department of Health.
335. Ward, J., Mattick, R.P., & Hall, W. (1992). Key Issues in Methadone Maintenance Treatment . Sydney: New South Wales University Press.
336. Ward, J., Mattick, R.P., & Hall, W. (1998). Methadone Maintenance Treatment and Other Opioid Replacement Therapies. Amsterdam: Harwood Academic Publishers.
337. Ward, J., Mattick, R.P., & Hall, W. (1998). The effectiveness of methadone maintenance treatment 2: HIV and infectious hepatitis. In: J. Ward, R.P. Mattick & W. Hall (eds), Methadone Maintenance Treatment and Other Opioid Replacement Therapies (pp 59-74). Amsterdam: Harwood Academic Publishers.
338. Ward, J., Mattick, R.P., & Hall, W. (1998). Assessment for opioid replacement therapy. In: J. Ward, R.P. Mattick & W. Hall (eds), Methadone Maintenance Treatment and Other Opioid Replacement Therapies (pp 177-203). Amsterdam: Harwood Academic Publishers.
339. Ward, J., Mattick, R.P. & Hall, W. (1998). The use of methadone during maintenance treatment: Pharmacology, dosage and treatment outcome. In: J. Ward, R.P. Mattick & W. Hall (eds), Methadone Maintenance Treatment and Other Opioid Replacement Therapies (pp 205-238). Amsterdam: Harwood Academic Publishers.
340. Ward, J., Mattick, R.P., & Hall, W. (1998).The use of urinalysis during opioid replacement therapy. In: J. Ward, R.P. Mattick & W. Hall (eds), Methadone Maintenance Treatment and Other Opioid Replacement Therapies (pp 239-264). Amsterdam: Harwood Academic Publishers.
341. Ward, J., Mattick, R.P., & Hall, W. (1998). How long is long enough? Answers to questions about the duration of methadone maintenance treatment. In: J. Ward, R.P. Mattick & W. Hall (eds), Methadone Maintenance Treatment and Other Opioid Replacement Therapies (pp 305-336). Amsterdam: Harwood Academic Publishers.
342. Ward, J., Mattick, R.P., & Hall, W. (1998). Making the transition from maintenance to abstinence: Detoxification from methadone maintenance treatment. In: J. Ward, R.P. Mattick & W. Hall (eds), Methadone Maintenance Treatment and Other Opioid Replacement Therapies (pp 337-358). Amsterdam: Harwood Academic Publishers.
343. Ward, J., Mattick, R.P., & Hall, W. (1998). Methadone maintenance during pregnancy. In: J. Ward, R.P. Mattick & W. Hall (eds), Methadone Maintenance Treatment and Other Opioid Replacement Therapies (pp 397-418). Amsterdam: Harwood Academic Publishers.
344. Ward, J., Mattick, R.P., & Hall, W. (1998).Psychiatric comorbidity among the opioid dependant. In: J. Ward, R.P. Mattick & W. Hall (eds), Methadone Maintenance Treatment and Other Opioid Replacement Therapies (pp 419-440). Amsterdam: Harwood Academic Publishers.
345. Ward, J., O'Connor, D., Mattick, R., & Hall, W. (1992). Translating research into policy: Methadone maintenance in New South Wales. In: J. White (ed), Drug problems in society: Dimensions and perspectives (pp 51-56). Parkside: Drug and Alcohol Services Council.
346. Warner-Smith, M., Lynskey, M., Darke, S., & Hall, W. (2001). Heroin overdose: Prevalence, correlates, consequences and interventions. Australian National Council on Drugs Research Paper 1. Canberra. (full report available)
347. Warner-Smith, M., Lynskey, M., Hall, W. & Montiero, M. (2001). Challenges and first approaches to estimating the burden of disease attributable to illicit drug use. In: J. Rehm and G. Gmel (eds), Alcohol, Illicit Drugs and Global Burden of Disease. Karger, Zurich.
348. Webster, P. & Jarvis, T. (1991). The Quality Assurance Project: Implications for Women. In: Changing the Research Story: Women and Drugs. Proceedings of the Women and Drugs Research Workshop, February 1991 Melbourne (pp 45-46). Melbourne: Addiction Research Institute of Victoria.
349. Webster, P., Mattick, R.P., & Baillie, A.J. (1991). Clients of Treatment Service Agencies: March 1990 Census Findings. Canberra: Australian Government Printing Service.
350. Wodak, A. (1990). AIDS and injecting drug use in Australia: A case study in policy development and implementation. In: J. Strang & G.V. Stimson (eds), AIDS and Drugs Misuse: The challenge for Policy and Practice in the early 1990s. London: Routledge.
351. Wodak, A. (1991). Alcoholism. In R.E. Rakel (ed), Conn’s Current Therapy. Section 16: Psychiatric Disorders (pp 1035-1040). W.B. Saunders Company.
352. Wodak, A. (1991). To shun the Heaven that leads man to this hell: AIDS and drug injection. In: I. Glass (ed), Handbook in Addiction Behaviour (pp 126-133). London: Routledge.
353. Wodak, A. (1992). Beyond the prohibition of heroin: The development of a controlled availability policy in Australia. In: P.A. O’Hare, R. Newcombe. A. Mathews, E.C. Buning, & E. Drucker (eds), The Reduction of Drug-Related Harm (pp 49-61). London: Routledge.
354. Wodak, A. (1992). Emergency presentations of alcohol and drugs. In: G.W.O Fulde (ed), Emergency Medicine: The Principles of Practice (pp 359-372). Sydney: Williams and Wilkins.
355. Wodak, A. (1998). Harm reduction as an approach to treatment. In: A.W. Graham & T.K. Schultz (eds), Principles of Addiction Medicine, second edition. (pp. 395-404). American Society of Addiction Medicine.
356. Wodak, A., Dwyer, R., Ross, M.W., Drury, M.J., Gold, J., & Miller, M.E. (1992). Life at the Epicentre: Sex and drug using behaviour in Sydney. Australian National AIDS and Injecting Drug Use Study, Sydney.
357. Wodak, A. & Gold, J. (1989). AIDS and intravenous drug use. In: R. Richmond & D. Wakefield (eds), Sexually transmitted infections and the AIDS epidemic. Harcourt, Brace and Jovanovich.
358. Wodak, A., Richmond, R..L, Webster, I.W., Scanlon, K., & Solomon, M. (1991). Alcoholscreen: Detection, assessment and minimal intervention for problem drinkers in general practice. In: J. Bell & L. Wyndham (eds), Screening for Drug Abuse – A Community Challege (pp 22-26). Clinical Biochemist Monograph No. 5 (Marylands, WA, Australian Association of Clinical Biologists).
359. Wodak, A., Shaw, J.M., Gaughwin, M.D., Ross, M.W., Miller, M.E., & Gold, J. (1991). Behind bars: HIV risk-taking behaviour of Sydney male drug injectors while in prison. In: J. Norberry, M. Gaughwin & S.A. Gerrull (eds), HIV/AIDS and Prisons: Proceedings of the Conference on AIDS in Prisons, 21 November 1990, Melbourne (pp 239-244). Canberra: Australian Institute of Criminology.